CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
26.14
+0.88 (3.48%)
Oct 13, 2026, 4:00 PM EDT - Market closed
CeriBell Revenue
CeriBell had revenue of $28.10M in the quarter ending June 30, 2026, with 32.54% growth. This brings the company's revenue in the last twelve months to $101.96M, up 31.70% year-over-year. In the year 2025, CeriBell had annual revenue of $89.06M with 36.09% growth. That makes CeriBell the 22,476th largest company in the world by revenue and 3,283rd in the United States.
Revenue (ttm)
$101.96M
Revenue Growth
+31.70%
P/S Ratio
9.84
Revenue / Employee
$311,817
Employees
327
Market Cap
1.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 89.06M | 23.62M | 36.09% |
| Dec 31, 2024 | 65.44M | 20.22M | 44.71% |
| Dec 31, 2023 | 45.23M | 19.30M | 74.47% |
| Dec 31, 2022 | 25.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CBLL News
- 11 days ago - Ceribell price target raised to $33 from $29 at TD Cowen - TheFly
- 13 days ago - Ceribell receives FDA 510k clearance of quantitative EEG trending, analysis - TheFly
- 13 days ago - Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis - GlobeNewsWire
- 4 weeks ago - Ceribell management to meet with BTIG - TheFly
- 1 month ago - Ceribell price target raised to $30 from $28 at BTIG - TheFly
- 2 months ago - CeriBell Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 2 months ago - Ceribell price target raised to $26 from $25 at Canaccord - TheFly
- 2 months ago - Ceribell reports Q2 EPS (51c), consensus (46c) - TheFly